Author response to Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database
Ther Adv Neurol Disord
.
2024 Sep 17:17:17562864241276848.
doi: 10.1177/17562864241276848.
eCollection 2024.
Authors
Afsaneh Shirani
1
,
Anne H Cross
2
,
Olaf Stuve
3
Affiliations
1
Department of Neurological Sciences, University of Nebraska Medical Center, 988440 Nebraska Medical Center, Omaha, NE 68198-8440, USA.
2
Department of Neurology, Washington University School of Medicine, St Louis, MO, USA.
3
Department of Neurology, University of Texas Southwestern Medical Center and Dallas VA Medical Center, Dallas, TX, USA.
PMID:
39314262
PMCID:
PMC11418341
DOI:
10.1177/17562864241276848
No abstract available